Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report

The treatment of stage IIIB non‐small cell lung cancer (NSCLC) is complicated, the best strategy is chosen individually and surgery is usually not recommended. A 50‐year‐old female was diagnosed with locally advanced lung adenocarcinoma (stage IIIB, T2bN3M0). Fluorescence in situ hybridization (FISH...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thorac Cancer
Main Authors: Bing, Zhongxing, Jia, Ziqi, Wang, Yadong, Xue, Jianchao, Cao, Lei, Cao, Zhili, Liu, Peng, Li, Ji, Liang, Naixin, Li, Shanqing
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons Australia, Ltd 2021
Teme:
Case Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8287007/
https://ncbi.nlm.nih.gov/pubmed/34105864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.14045
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki